Nirsevimab sharply cuts RSV hospitalizations in U.S. infants during the 2024–2025 season

Orientul Mijlociu

By Vijay Kumar Malesu Reviewed by Susha Cheriyedath, M.Sc. Sep 28 2025 Real-world data confirm that nirsevimab provides powerful protection for infants, reducing RSV hospital stays and easing the strain on families and healthcare systems. Research letter: Nirsevimab Administration and RSV Hospitalization in the 2024-2025 Season . Image Credit: Bonn_A  / Shutterstock In a recent Research Letter published in the  JAMA Network Open , a group of researchers estimated whether nirsevimab, a long-

din zilele anterioare